Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

CFRX
ContraFect Corp
stock NASDAQ

At Close
10/2/2023 3:54:30 PM EDT
0.5400USD-8.319%(-0.0490)18,602
0.4240Bid   0.6600Ask   0.2360Spread IEX
Pre-market
10/2/2023 9:13:30 AM EDT
0.5899USD+0.153%(+0.0009)0
After-hours
9/27/2023 4:02:30 PM EDT
0.5520USD+4.151%(+0.0220)0
OverviewHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
2.958M
Headquarters
Yonkers, New York, USA
Industry
Biotechnology
Last Split
2023-02-151for80reverse
Related
VIVOVTLALDXXLV
CFRX Stats
Avg. Vol. 10 Day
25,927
Avg. Vol. 30 Day
74,061
Employees
23
Market Cap
2,958,008
Shares Out.
5,477,803
Float
3,641,845
On/Off Exchange
38%/62%
6 Month Beta
3.37
1 Year Beta
1.59
2 Year Beta
1.36
3 Year Beta
1.38
52 Week Low
0.51
52 Week High
15.76
SMA50
0.71
SMA200
1.33
1 Week
-6.90%
1 Month
-30.57%
3 Month
-63.27%
6 Month
-65.93%
1 Year
-96.06%
2 Year
-99.83%
5 Year
-99.97%
Profile
we are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. due to drug-resistant and newly-emerging pathogens, infections in the hospital are already the fourth leading cause of death in the united states, following heart disease, cancer and stroke. we address multi-drug resistant infections using our therapeutic products from our lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. our strategy is to use our first in class therapies to achieve a leadership position in the treatment of life-threatening infectious diseases, including drug-resistant pathogens. we plan to pursue commercialization of therapeutic products through discovery, acquisition and development of protein and antibody products. our novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills ba

CFRX Stock Summary

ContraFect Corp (NASDAQ:CFRX) stock price today is $0.5400, and today's volume is 18,602. CFRX is down -8.319% today. The 30 day average volume is 74,061. CFRX market cap is 2.958M with 5,477,803 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC